GlassScriptPhysician profile
Christopher G Maliken
NPI 1811332331
$5,019.26
in general payments reported to CMS, 2019-2025
7 companies · $3,863 in 2025
The $3,863 reported for 2025 was more than what 96% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $150 · 2021: $375 · 2022: $275 · 2023: $185 · 2024: $171 · 2025: $3,863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,058 · Food and Beverage: $1,827 · Gift: $170 · Education: $125 · Entertainment: $39.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,057.60 |
| Food and Beverage | $1,826.89 |
| Gift | $170.00 |
| Education | $125.00 |
| Entertainment | $39.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,913.26 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $525.00 | 2020-2021 | |
| Zimvie INC. | $228.50 | 2022-2024 | |
| Stryker Corporation | $156.66 | 2025 | Vsp System, Vsp Cranial |
| Geistlich Pharma, North America, INC. | $99.68 | 2024 | Geistlich Bio-Gide |
| Dentsply Sirona INC | $50.93 | 2022 | |
| Smith+Nephew, INC. | $45.23 | 2024-2025 | Stravix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Maliken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.